
Alkem has been operating in Philippines since July 2011 through its wholly owned subsidiary, Alkem Laboratories Corporation. The company offers a wide range of specialty products across multiple therapeutic segments. It began with Anti-infectives and later expanded into Gastroenterology with Proton Pump Inhibitors. The portfolio has recently grown to include Pain Management and Probiotic therapies. Alkem aims to strengthen its presence through continuous and strategic product launches while building a strong prescription base. A dedicated team of medical representatives and managers actively supports brand growth across the Philippines.
Small (30 to 99 employees)
Biotechnology & Pharmaceuticals
Source: Great Place to Work® 2021 Global Employee Engagement Study
